Inventiva (IVA) Equity Income (2023)

Inventiva's (IVA) quarterly Equity Income came in at -$2.2 million in Q4 2023.

Inventiva (IVA) Equity Income (2023) Analysis & Trends

Inventiva's Equity Income history runs 1 years deep, the most recent figure standing at -$2.2 million for Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Income (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Inventiva	842.48 Mn	842.48 Mn	-	-

Download Data

Date	Value
Dec 31, 2023	-2.17 Mn